Mindspark Logo featuring a stylized brain in blue and purple with green leaves at the bottom.
Blogs

Why More People in Orange County Are Trying to Calm Inflammation at the Source with KPV Peptide Therapy

By Mindspark Health

Go back

Peptide Therapy in Brea, Orange County, California - Serving Patients Across California, Arizona, Nevada, Oregon & Washington

A Different Approach to Inflammation

Chronic inflammation is now understood to be at the root of many modern health concerns, including digestive issues, skin conditions, immune dysregulation, and long term systemic imbalance.


Many people across Brea, Fullerton, Anaheim, Irvine, and throughout Orange County are beginning to notice patterns such as

This has led to growing interest in more targeted approaches that work with the body’s natural systems. One peptide that continues to come up in both research and clinical conversations is KPV.

What Is KPV

KPV (Lys Pro Val) is a tripeptide, meaning it is made up of three amino acids: lysine, proline, and valine.


It is derived from the C terminal end of alpha melanocyte stimulating hormone, also known as a MSH, which is one of the body’s most powerful natural anti-inflammatory compounds.


Extensive research has shown that α MSH can regulate inflammation across multiple systems including the gut, skin, brain, lungs, and immune system. However, its clinical use has been limited because it also stimulates melanin production, which can lead to unwanted pigmentation changes.


KPV is unique because it retains the anti-inflammatory properties of α MSH while eliminating its pigmentary effects, making it a more targeted and practical therapeutic option.

How KPV Works

KPV works through several key biological pathways that regulate inflammation at its source
1. NF κB Inhibition

NF κB is considered the master switch of inflammation. When activated, it triggers the release of inflammatory signals such as TNF α, IL 1β, and IL 6. KPV has been shown to inhibit NF κB and MAP kinase pathways at very low concentrations, helping reduce the overall inflammatory response at a foundational level.

2. PepT1 Transport System

KPV enters cells through a transporter called PepT1, which is naturally present in the gut and becomes more active during inflammation. This means that in inflamed intestinal tissue, KPV is preferentially absorbed exactly where it is needed most, making it especially relevant for gut related conditions.

3. IL 1β Modulation

KPV appears to act independently of traditional melanocortin receptors and instead works by inhibiting IL 1β, one of the most potent inflammatory signaling molecules in the body. This allows it to function across a wide range of tissues without relying on a single receptor pathway.

4. Reduction of Inflammatory Cell Migration
KPV reduces the movement of inflammatory immune cells such as neutrophils into affected tissues, helping limit tissue damage and excessive inflammatory response.

What the Research Shows: Gut Health and Inflammatory Bowel Conditions KPV has shown particularly strong results in models of inflammatory bowel disease

What the Research Shows: Skin Inflammation and Wound Healing

KPV and related peptides have demonstrated benefits in


Studies suggest KPV can reduce inflammation, support tissue regeneration, and improve skin barrier function.


Antimicrobial Effects
KPV has demonstrated the ability to inhibit common pathogens such as Staphylococcus aureus and Candida albicans


Unlike traditional anti-inflammatory medications, KPV does not suppress immune defense.
Instead, it may enhance the body’s ability to respond to infections while reducing excessive inflammation


Systemic Inflammation
Modified versions of KPV have shown the ability to reduce systemic inflammatory markers such as TNF α and nitric oxide in both cellular and animal models


Respiratory and Allergic Inflammation

Research suggests KPV related pathways may help reduce


Joint and Inflammatory Conditions
KPV related peptides have been identified as a potential class of anti inflammatory and immune regulating compounds with relevance for joint inflammation and early stage arthritis

Cardiovascular and Vascular Health
Emerging research suggests KPV may help reduce vascular calcification by addressing inflammation and supporting cellular cleanup processes such as autophagy


Neuroinflammation and Brain Health
While still being explored, melanocortin pathways associated with KPV have demonstrated neuroprotective effects including

Safety Profile

KPV has demonstrated a strong safety profile in research

As with all peptide therapies, proper sourcing and medical supervision are essential

Who May Benefit from KPV

KPV may be considered for individuals experiencing

How KPV Is Used at Mindspark Health

At Mindspark Health in Brea, Orange County, KPV is part of a structured, personalized approach

This may include

KPV may be used in different forms depending on the goal, including oral, subcutaneous, or topical approaches

It is often combined with other peptides for synergistic support

Where can I get KPV therapy?

Mindspark Health in Brea, Orange County provides KPV therapy as part of personalized care plans for patients across California, Arizona, Nevada, Oregon, and Washington

Why Patients Choose Mindspark Health

Patients across Brea, Fullerton, Anaheim, Irvine, Newport Beach, and beyond choose


Mindspark Health for

A Final Thought

Inflammation is not always obvious, but over time it can affect nearly every system in the body. KPV represents a targeted way to support how the body regulates inflammation at its source. Not by forcing change, but by helping restore balance where it has been disrupted.


Ready to Take the Next Step?

If you are exploring KPV peptide therapy in Orange County or Brea, or looking for a more targeted approach to inflammation, we are here to help! Call or text (714) 695 5837 to learn more or schedule a consultation

References

1. Brzoska T, Luger TA, Maaser C, Abels C, Böhm M. Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocrine Reviews. 2008;29(5):581-602. doi:10.1210/er.2007-0027


2. Luger TA, Brzoska T. Alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs. Annals of the Rheumatic Diseases. 2007;66 Suppl 3:iii52-5. doi:10.1136/ard.2007.079780


3. Brzoska T, Böhm M, Lügering A, Loser K, Luger TA. Terminal signal: anti-inflammatory effects of α-melanocyte-stimulating hormone related peptides beyond the pharmacophore. Advances in Experimental Medicine and Biology. 2010;681:107-16. doi:10.1007/978-1-4419-6354-3_8*


4. Luger TA, Scholzen TE, Brzoska T, Böhm M. New insights into the functions of alpha-MSH and related peptides in the immune system. Annals of the New York Academy of Sciences. 2003;994:133-40. doi:10.1111/j.1749-6632.2003.tb03172.x


5. Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-78. doi:10.1053/j.gastro.2007.10.026


6. Getting SJ, Schiöth HB, Perretti M. Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides. The Journal of Pharmacology and Experimental Therapeutics. 2003;306(2):631-7. doi:10.1124/jpet.103.051623


7. Kannengiesser K, Maaser C, Heidemann J, et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflammatory Bowel Diseases. 2008;14(3):324-31. doi:10.1002/ibd.20334


8. Xiao B, Xu Z, Viennois E, et al. Orally targeted delivery of tripeptide KPV via hyaluronic acid-functionalized nanoparticles efficiently alleviates ulcerative colitis. Molecular Therapy. 2017;25(7):1628-1640. doi:10.1016/j.ymthe.2016.11.020


9. Sun J, Xue P, Liu J, et al. Self-cross-linked hydrogel of cysteamine-grafted γ-polyglutamic acid stabilized tripeptide KPV for alleviating TNBS-induced ulcerative colitis in rats. ACS Biomaterials Science Engineering. 2021;7(10):4859-4869. doi:10.1021/acsbiomaterials.1c00792


10. Luger TA, Scholzen TE, Brzoska T, Böhm M. New insights into the functions of alpha-MSH and related peptides in the immune system. Annals of the New York Academy of Sciences. 2003;994:133-40. doi:10.1111/j.1749-6632.2003.tb03172.x


11. Böhm M, Luger T. Are melanocortin peptides future therapeutics for cutaneous wound healing? Experimental Dermatology. 2019;28(3):219-224. doi:10.1111/exd.13887

12. Adnan SB, Maarof M, Fauzi MB, Fadilah NIM. Exploring the role of tripeptides in wound healing and skin regeneration: a comprehensive review. International Journal of Medical Sciences. 2025;22(16):4175-4200. doi:10.7150/ijms.118118


13. Pawar K, Kolli CS, Rangari VK, Babu RJ. Transdermal iontophoretic delivery of lysine-proline-valine (KPV) peptide across microporated human skin. Journal of Pharmaceutical Sciences. 2017;106(7):1814-1820. doi:10.1016/j.xphs.2017.03.017


14. Cutuli M, Cristiani S, Lipton JM, Catania A. Antimicrobial effects of alpha-MSH peptides. Journal of Leukocyte Biology. 2000;67(2):233-9. doi:10.1002/jlb.67.2.233


15. Singh M, Mukhopadhyay K. Alpha-melanocyte stimulating hormone: an emerging anti-inflammatory antimicrobial peptide. BioMed Research International. 2014;2014:874610. doi:10.1155/2014/874610


16. Gatti S, Carlin A, Sordi A, et al. Inhibitory effects of the peptide (CKPV)2 on endotoxin-induced host reactions. The Journal of Surgical Research. 2006;131(2):209-14. doi:10.1016/j.jss.2005.08.009


17. Zhang L, Li D, Aierken Y, et al. KPV and RAPA self-assembled into carrier-free nanodrugs for vascular calcification therapy. Advanced Healthcare Materials. 2024;13(32):e2402320. doi:10.1002/adhm.202402320


18. Catania A. Neuroprotective actions of melanocortins: a therapeutic opportunity. Trends in Neurosciences. 2008;31(7):353-60. doi:10.1016/j.tins.2008.04.002


19. Mykicki N, Herrmann AM, Schwab N, et al. Melanocortin-1 receptor activation is neuroprotective in mouse models of neuroinflammatory disease. Science Translational Medicine. 2016;8(362):362ra146. doi:10.1126/scitranslmed.aaf8732

Read more from Mindspark

Evidence-based insights, patient stories, and actionable tips for your health journey.

Ready to Get Started?

Take the first step toward understanding your health and creating a personalized path to wellness.

Contact Us

Thank you for contacting us!

We will get in touch with you!
Cartoon gray and white cat wearing a purple hoodie and green sneakers, winking and raising one paw.
Oops! Something went wrong while submitting the form.
Circular light blue shape with a small irregular black dot near its center.

Want more updates and free resources from Mindspark Health?

Join our newsletter and receive weekly health tips, exclusive guides, and early access to new programs.